A Goodwin cross-border team represented the neuroscience company Cerevance in its launch by Lightstone Ventures and Takeda Pharmaceutical. Cerevance will focus on discovering and developing novel…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
